Glucocorticosteroids and HELLP syndrome - Current status;Glukokortikoide und HELLP-Syndrom. Eine standortbestimmung

Gynakologe

Volumn 32, Issue 10, 1999, Pages 783-790

  Fischer, T ^a   Wildt, L ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b NONE

Author keywords

Fetal and maternal morbidity and mortality; Gucocorticosteroids; HELLP syndrome; Preeclampsia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GLUCOCORTICOID; LACTATE DEHYDROGENASE;

FETUS MORTALITY; HELLP SYNDROME; HUMAN; MATERNAL MORBIDITY; MATERNAL MORTALITY; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PREMATURITY; REVIEW; STEROID THERAPY; THROMBOCYTE;

EID: 0032888290     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00003184     Document Type: Review

References (52)

1. Aarnoudse JG, Houthoff HJ, Weits J, Vellenga E, Huisjes HJ (1986) A syndrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy: a clinical and histopathological study. Br J Obstet Gynecol 92: 145-155
2. Allolio B, Hoffmann J, Linton EA, Winkelmann W, Kusche M, Schulte HM (1990) Diurnal salivary cortisol patterns during pregnancy and after delivery: relationship to plasma corticotrophin-releasing-hormone. Clin Endocrinol (Oxf) 33: 279-289
3. Blanford AT, Murphy BE (1977) In vitro metabolism of prednisolone, dexamethason, betamethasone and cortisol bx the human placenta. Am J Obstet Gynecol 127: 264-267
4. Boy K, Zimmermann U, Wildt L (1995) Enhanced tumor necrosis factor alpha (TNF alpha) secretion by stimulated mononuclear leucocytes in gestosis. Exper Clin Endocinol Diabetes 103 [Suppl 1]:42 (abstract)
5. Cartlidge PH, Stewart JH (1997) Survival of very low birthweight and very preterm infants in a geographically defined population. Acta Paediatr 86: 105-110
6. Clark SL, Phelan JR, Allen SH, Golde SR (1986) Antepartum reversal of hematologic abnormalities associated with the Hellp-syndrome. J Reprod Med 31: 70-72
7. Del Rio G, Velardo A, Zizzo G et al. (1994) Effect of estradiol on the sympathadrenal response to mental stress in normal men. J Clin Endocrinol Metab 79: 836-840
8. Dupont E, Wybran J, Toussaint C (1984) Glucocorticosteroids and organ transplantation. Transplantation 37: 331-335
9. Ettinger SM, Silber DH, Gray KS, Smith MB, Yang QX, Kunselman AR, Sinoway LI (1998) Effects of the ovarian cycle on sympathetic neural aotflow during static exercise. J Appl Physiol 85: 2075-2081
10. Fischer T, Schneider M, Lang N (1998) C-reaktives Protein beim HELLP-Syndrom. Arch Gynecol Obstet 261 [Suppl 1]:45 (abstract)
11. Fischer T, Krause M, Beinder E, Schlembach D, Rabenbauer B, Wildt L, Lang N (1999) Schwangerschaftsverlängerung bei Patientinnen mit HELLP-Syndrom. Geburtshilfe Frauenheilkd 59: 335-345
12. Geary M (1997) The HELLP-Syndrome. Br J Obstet Gynaecol 104: 887-891
13. Hack M, Friedman H, Fanaroff AA (1996) Outcomes of extremely low birth weight infants. Pediatrics 98: 931-937
14. Hackenberg H, Rappe N, Wohlers S, Meyer-Wittkopf M, Schulz KD (1998) Wertigkeit des C-reaktiven Proteins (CRP) beim HELLP-Syndrom. Geburtshilfe Frauenheilkd 58: 508-512
15. Hamm W, Richardsen G, Bolte A (1996) Die Bedeutung der frühzeitigen Diagnose und unverzüglichen Entbindung bei Patientinnen mit HELLP-Syndrom. Geburtshilfe Frauenheilkd 56: 649-653
16. He XR, Wang W, Crofton JT, Share L (1998) Effects of 17beta-estradiol on sympathetic activity and pressor response to phenylephrine in ovariectomized rats. Am J Physiol 275: 1202-1208
17. Heller CS, Elliot JP (1997) High-order multiple pregnancies complicated by HELLP syndrome. A report of four cases with corticosteroid therapy to prolong gestation. J Reprod Med 42: 743-746
18. Heyborne KD, Burke MS, Porreco RP (1990) Prolongation of premature gestation in women with hemolysis, elevated liver enzymes, and low platelets. A report of 5 cases. J Reprod Med 35: 53-57
19. Kändler C, Kevekordes B, Zenker M, Kandler M, Beinder E, Lang N, Harms D (1998) Prognosis of children born to mothers with HELLP-Syndrome. J Perinat Med 26: 486-490
20. Kanyama N, She L, Maehara K, Kajiwara Y, Terao T (1996) Induction of HELLP syndrome-like biochemical parameters by stimulation of the celiac ganglion in rats. J Hypert 14: 453-459
21. th world congress of the International society for the Study of Hyperetension in Pregnancy; Abstractband:140
22. Killam AP, Dillard SH, Patton RC, Pederson PR (1975) Pregnancy-induced hypertension complicated by acute liver disease and disseminated intravascular coagulation. Am J Obstet Gynecol 123: 823-828
23. Louwen F, Stuessel J, Klezsel AE, Schneider HPG (1996) Der Einfluß des Geburtsmodus und der fetomaternalen Zirkulation auf den Laborverlauf des HELLP-Syndroms. Archives Gynecol Obstet 258 [Suppl 1]:115 (abstract)
24. MacKenna J, Dover NL, Brame RG (1983) Preeclampsia associated with hemolysis, elevated liver enzymes, and low platelets - an obstetric emergency? Obstet Gynecol 62: 751-754
25. Magann EF, Graves GR, Roberts WE, Blake PG, Morrison JC, Martin JN (1993) Corticosteroids for enhanced fetal lung maturation in patients with HELLP syndrome: impact on neonates. Aust NZ J Obstet Gynaecol 33: 231-235
26. Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin JN (1994) Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 171: 1148-1153
27. Magann EF, Perry KG, Meydrech EF, Harris RL, Chauhan SP, Martin JN (1994) Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 171: 1154-1158
28. Martin JN, Perry KG, Miles JF, Blake PG, Magann EF, Roberts WE, Martin RW (1993) The interrelationship of eclampsia, HELLP syndrome, and prematurity: cofactors for significant and perinatal risk. Br J Obstet Gynaecol 100: 1095-1100
29. Pritchard JA, Weisman R, Ratnoff OD, Vosburgh GJ (1954) Intravascular hemolysis, thrombocytopenia and other hematolpgic abnormalities associated with severe toxemia of pregnancy. N Engl J Med 250: 89-98
30. Rabenbauer B, Schult P, Fischer T, Wildt L (1996) Hochdosierte Kortikosteroidtherapie beim HELLP-Syndrom. Archives Gynecol Obstet 258 [Suppl 1]:114 (abstract)
31. Rath W, Loos W, Kuhn W, Graeff H (1990) The importance of early laboratory screening methods for maternal and fetal outcome in cases of HELLP-Syndrome. Eur J Obstet Gynecol Reprod Biol 36: 43-51
32. Rath W, Loos W, Kuhn W (1994) Das HELLP-Syndrom. Zentalb Gynäkol 116: 195-201
33. Rath W (1996) Aggressives versus konservatives Vorgehen beim HELLP-Syndrom -eine Standortbestimung. Geburtshilfe Frauenheilkd 56: 265-271
34. Reubinoff BE, Schenker JG (1991) HELLP-Syndrome - a syndrome of hemolysis, elevated liver enzymes and low platelet count - Complicating preeclampsia-eclampsia. Int J Gynecol Obstet 36: 95-102
35. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE (1996) Preeclampsia - a state of sympathetic overactivity. N Engl J Med 335: 1480-1485
36. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM (1986) Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 155: 501-509
37. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA (1993) Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169: 1000-1006
38. 2 serotonergic receptor antagonist, could be useful in the HELLP syndrome. Hypertension in Pregnancy 12: 183-190
39. Spitzer D, Steiner H, Schaffer H, Staudach A (1993) Gibt es ein intermittierendes HELLP-Syndrom? Z Geburtsh Perinat 197: 84-86
40. Sliutz G, Schäfer B, Obwegeser R, Joura E, Hammerle A, Dadak C (1993) Geburtshilfliches Management bei Patientinnen mit HELLP-Syndrom. Z Geburtshilfe Perinat 197: 112-118
41. Stahnke E (1922) Über das Verhalten der Blutplättchen bei der Präeklampsie. Zentralbl Gynäkol 46: 391-392
42. Stevenson DK, Wright LL, Lemons JA et al. (1998) Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, january 1993 through december 1994. Am J Obstst Gynecol 179: 1632-1639
43. Thiagarajah S, Bourgeois J, Harbert G, Caudle M (1984) Thrombozytopenia in preeclampsia: associated abnormalities and management principles. Am J Obstet Gynecol 150: 1-7
44. Van Dam PA, Renier MM, Baekelandt M, Buytaert P, Uyttenbroeck F (1989) Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets. Obstet Gynecol 73: 97-102
45. van Pampus MG, Wolf H, Westenberg SM, van der Post JAM, Bonsel GJ, Treffers PE (1998) Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 76: 31-36
46. Visser W, Wallenburg HCS (1995) Temporising management of severe preeclampsia with and without HELLP syndrome. Br J Obstet Gynecol 102: 111-117
47. Ward RM (1994) Pharmacologic enhancement of fetal lung maturation. Clin Perinat21: 523-542
48. Weinstein L (1982) Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142: 159-167
49. Weinstein L (1985) Preeclampsia/Eclampsia with hemolysis, elevated liver enzymes, and thrombocytopenia. Obstet Gynecol 66: 657-660
50. Welsch H, Krone A (1994) Mütterliche Mortalität beim HELLP-Syndrom in Bayern 1983-1992. Zentralb Gynäkol 116: 202-206
51. White PC, Curnow KM, Pascoe L (1994) Disorders of steroid 11ß-hydroxylase isoenzymes. Endocr Rev 15: 421-438
52. Winkler M, Heyl W, Reister F, Rath W (1996) Beeinflußt die Lungenreifetherapie mit 16-Methylen-Prednisolon die mütterlichen Infektionsparameter bei drohender Frühgeburt. Geburtshilfe Frauenheilkd 56: 317-321